Beruflich Dokumente
Kultur Dokumente
Dr. V N Bhattathiri MD PhD Professor of Radiology Academy of Medical Sciences Pariyaram Medical College PO Kannur-670503
Degenerative Neoplastic
Cancer
Aim of treatment
Curative Cure: Disease free life expectancy equal to normal population Usually intense Symptom control Usually less intense
Tumour
Site & Histology
Extent
Host
Performance status Age, organ function
Treatment Modalities
Surgery
Solid tumours Principle: Remove macroscopic as well as microscopic (ie potentially involved) tumour
Limited by site and extent of tumour Repair at time of surgery Curative; Emergency
Surgery
Adenocarcinomas Breast; Stomach, Colorectal, Ovarian, Uterus Salivary gland, Thyroid Squamous cell carcinomas
Head and neck; Uterine cervix; Skin, Lung Oesophagus
Radiotherapy
Radiotherapy
Radiation
Electromagnetic: X-rays or -rays
Source
Machines: Linear accelerators, cyclotrons Radioactive isotopes: Cobalt, Iridium, Cesium, etc.
Tumour
Site: Critical organs: Eye, Spinal cord Growth rate: Potential doubling time
Host
Age Performance status Other diseases Anemia
Treatment factors
Fraction size Interruptions
Dose
Radiation used Planning
Radiotherapy
Delivered by
Teletherapy Brachytherapy Internal therapy
Radiotherapy
Teletherapy
Source kept at a distance from body Irradiates all tissues between skin and tumour Use multiple fields
Radiotherapy
Brachytherapy
Radioactive Source kept close to or inside body Intracavitary, intraluminal, interstitial, etc High tumour dose, low normal tissue dose
Radiotherapy
Internal therapy
Injected or ingested unsealed radionuclides Radioiodine : Thyroid; Strontium: Bone mets
Radiotherapy
Curative
Head and neck cancers Uterine cervix Lymphomas
Adjuvant
To surgery: Breast, brain, sarcomas, etc
Symptomatic
Bone mets, lung,
Chemotherapy
DNA damagers:
Alkylating agents, Bleomycin
Antimetabolites:
Methotrexate, 5FU, 6MP
Topoisomerase inhibitors:
Etoposide, Adriamycin, Actinomycin-D
Biological therapy
Interferons
Antiproliferative, Differentiating; Alter cell
Interleukins
Immune stimulator, induce cytokines (TNF,
lymphotoxin, etc.)
Biological therapy
Hormonal agents
Estrogens, Antioestrogens, Progesterones,
Differentiating agents
ATRA & Arsenic trioxide-APL;
13cisRetinoicacid-Mycosis fungoides
Biological therapy
Monoclonal antibodies
Anti-CD20 (Rituximab): Low grade NHL Anti-HER2/neu (Trastuzumab): Breast
Angiogenesis inhibitors
Thalidomide-Myeloma
Gene therapy
Suicide gene
HSV-TK, cytosine deaminase Brain trs, mesothelioma Use retro and adenoviruses
Tr suppressor gene
P53, BRCA1, retinoblastoma, p16 Lung, colon, ovarian Use retro and adenoviruses
Hyperthermia
Temperatures of 42-450 C Perfusion: local, body cavities Microwave Radiofrequency With chemotherapy, radiotherapy, immunotherapy
Other techniques
Photodynamic therapy
Laser surgery Cryosurgery
Combined modalities
Team management